CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone

Core Insights - The article discusses potential investment opportunities in LLY, indicating a possible long position within the next 72 hours [1]. Group 1 - The analyst has no current stock or derivative positions in the companies mentioned but may initiate a beneficial long position in LLY [1]. - The article expresses the author's own opinions and is not influenced by compensation from any company [1]. - There is no business relationship with any company whose stock is mentioned in the article [1].